This process is driven by upregulation of the OXPHOS complex and subsequent activation of TGFβ-SMAD and MAPK signaling pathways, which promote epithelial-mesenchymal transition (EMT) and facilitate bone metastasis of breast cancer cells. The gene discussed is TGFB1; the disease is breast carcinoma.